• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rapid and sustained response to spesolimab in five Chinese patients with generalized pustular psoriasis.

作者信息

Ran Delin, Yang Baoqi, Sun Lulu, Wang Na, Qu Peng, Liu Jing, Pan Futang, Wang Guangjin, Wu Weizhi, Zhang Zhaoxia, Shi Zhongxiang, Yang Qing, Liu Hong, Zhang Furen

机构信息

Department of Dermatology, Shandong Provincial Hospital for Skin Diseases and Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

出版信息

Clin Exp Dermatol. 2023 Jul 7;48(7):803-805. doi: 10.1093/ced/llad108.

DOI:10.1093/ced/llad108
PMID:36994823
Abstract
摘要

相似文献

1
Rapid and sustained response to spesolimab in five Chinese patients with generalized pustular psoriasis.五例中国泛发性脓疱型银屑病患者对司库奇尤单抗的快速持续反应
Clin Exp Dermatol. 2023 Jul 7;48(7):803-805. doi: 10.1093/ced/llad108.
2
Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study.斯帕利单抗治疗泛发性脓疱型银屑病亚洲患者的疗效和安全性：Effisayil™ 1 研究的随机、双盲、安慰剂对照结果。
J Dermatol. 2023 Feb;50(2):183-194. doi: 10.1111/1346-8138.16609. Epub 2022 Oct 25.
3
Spesolimab rapidly treats generalized pustular psoriasis and improves the skin immune microenvironment in Chinese patients.斯佩索利单抗可快速治疗中国患者的泛发性脓疱型银屑病并改善皮肤免疫微环境。
Clin Immunol. 2024 Aug;265:110280. doi: 10.1016/j.clim.2024.110280. Epub 2024 Jun 14.
4
Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study.在随机、安慰剂对照的 Effisayil 1 研究中，spesolimab 治疗泛发性脓疱型银屑病发作，可迅速和持续改善全身性脓疱性银屑病医师总体评估评分。
J Am Acad Dermatol. 2023 Jul;89(1):36-44. doi: 10.1016/j.jaad.2023.02.040. Epub 2023 Mar 2.
5
Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares in Adult Patients.斯帕索单抗，一种新型白细胞介素-36 抑制剂，用于治疗成人泛发性脓疱型银屑病发作。
Skin Therapy Lett. 2024 Jan;29(1):1-4.
6
Trial of Spesolimab for Generalized Pustular Psoriasis.特索利单抗治疗泛发性脓疱型银屑病的试验。
N Engl J Med. 2021 Dec 23;385(26):2431-2440. doi: 10.1056/NEJMoa2111563.
7
Spesolimab: A Novel Treatment for Pustular Psoriasis.斯佩索利单抗：脓疱型银屑病的一种新型治疗方法。
J Cutan Med Surg. 2020 Mar/Apr;24(2):199-200. doi: 10.1177/1203475419888862.
8
Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors.泛发性脓疱型银屑病：白细胞介素-36 受体抑制剂治疗的新时代。
J Dermatolog Treat. 2022 Nov;33(7):2911-2918. doi: 10.1080/09546634.2022.2089335. Epub 2022 Jun 21.
9
Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis.斯帕索单抗，一种白细胞介素-36 受体单克隆抗体，用于治疗泛发性脓疱型银屑病。
Expert Rev Clin Immunol. 2023 May;19(5):473-481. doi: 10.1080/1744666X.2023.2195165. Epub 2023 Mar 28.
10
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study.在 Effisayil 1 研究中，spesolimab 治疗泛发性脓疱型银屑病发作的疗效在预先指定的患者亚组中。
Exp Dermatol. 2023 Aug;32(8):1279-1283. doi: 10.1111/exd.14824. Epub 2023 May 4.

引用本文的文献

1
Rapid improvement in a recurrent generalized pustular psoriasis patient ineffective to Ixekizumab following Spesolimab therapy.司库奇尤单抗治疗无效的复发性泛发性脓疱型银屑病患者在接受斯佩索利单抗治疗后病情迅速改善。
An Bras Dermatol. 2025 May-Jun;100(3):634-637. doi: 10.1016/j.abd.2024.09.003. Epub 2024 Dec 30.
2
Successful Treatment of Pediatric Generalized Pustular Psoriasis (GPP) with Spesolimab: 5 Case Reports and Evaluations of Circulating IL-36 Levels.司库奇尤单抗成功治疗儿童泛发性脓疱型银屑病（GPP）：5例病例报告及循环IL-36水平评估
J Inflamm Res. 2024 Nov 4;17:8199-8206. doi: 10.2147/JIR.S485077. eCollection 2024.
3
Spesolimab for generalized pustular psoriasis: a review of two key clinical trials supporting initial US regulatory approval.
斯佩索利单抗治疗泛发性脓疱型银屑病：两项关键性临床试验的综述，支持该药在美国的初始监管批准。
Front Immunol. 2024 Jul 22;15:1359481. doi: 10.3389/fimmu.2024.1359481. eCollection 2024.
4
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.司库奇尤单抗成功治疗合并泛发性脓疱型银屑病的Hallopeau连续性肢端皮炎：一例报告
Front Immunol. 2024 Feb 23;15:1338285. doi: 10.3389/fimmu.2024.1338285. eCollection 2024.
5
Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence.泛发性脓疱型银屑病患者的临床特征与疾病负担：真实世界证据综述
Dermatol Ther (Heidelb). 2024 Feb;14(2):341-360. doi: 10.1007/s13555-024-01103-5. Epub 2024 Feb 16.
6
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?生物疗法在脓疱型银屑病治疗中的应用：新时代来临？
Clin Cosmet Investig Dermatol. 2023 Jun 28;16:1677-1690. doi: 10.2147/CCID.S407812. eCollection 2023.